Project Grant R21DE033120

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $251K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Kansas City, MO 64108, USA
Similar Awards
This National Institute of Dental and Craniofacial Research (NIDCR) Project Grant award under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $320,053 to the University of Southern California (USC) to conduct comprehensive research on the craniofacial skeleton and connective tissue development. The 8-year project will utilize advanced techniques in spatial transcriptomics and mouse genetics to identify genes and pathways regulating the assembly of the craniofacial...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $600,029 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Cedars-Sinai Medical Center. The grant, which runs from March 10, 2025 to February 28, 2030, supports research to elucidate the molecular and cellular mechanisms by which Ras/MAPK signaling dysregulation causes abnormal enamel formation and craniofacial development. The research aims to determine how Ras signaling disruption...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $178,848 five-year Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to The Regents of the University of California, San Francisco (UCSF) to study the role of the p120-catenin protein in craniofacial development and disease. The project aims to elucidate the molecular mechanisms underlying cleft lip formation, leveraging newly developed mouse models and live imaging approaches to understand how...
This federal Project Grant award, valued at $294,000 and spanning September 2024 to September 2026, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to understand the mechanisms of craniofacial cartilage differentiation from human neural crest stem cells, with the goal of developing tissue engineering approaches to repair birth defects and injuries to the head and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $452,681 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Regents of the University of California, San Francisco (UCSF) for the project "Control of Mammalian Craniofacial Morphogenesis by the ESCRT Machinery". The research aims to determine the tissue-specific roles of the ESCRT machinery in regulating signaling pathways and lipid metabolism during mammalian...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $302,318 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to Rutgers, The State University. The grant will fund research to investigate the effects of skull malformations and intracranial hypertension on the glymphatic and meningeal lymphatic systems in craniosynostosis. Key aims include testing if impaired glymphatic (cerebrospinal fluid) influx and efflux impedes the clearance of...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to establish a novel zebrafish model of syndromic craniosynostosis. The $313,000 award to Emory University will enable comprehensive phenotypic, mechanistic, and genetic analyses of the craniosynostosis mutant zebrafish to better understand the underlying pathological mechanisms. The research aims to identify...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $161,644 to Seattle Children's Hospital to conduct a multifaceted investigation of speech outcomes after maxillary advancement surgery for individuals with cleft palate. The study aims to: 1) investigate anatomic risk factors associated with post-operative velopharyngeal insufficiency, 2) quantify the relationship...
This Project Grant award, totaling $313,000.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program. The award will fund a secondary analysis of whole genome sequencing data from the Gabriella Miller Kid's First (GMKF) orofacial cleft cohorts to identify genetic variants located within regulatory elements active in the facial ectoderm, as well as investigate deep intronic variants in...
This $453,750 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate the genetic and cellular mechanisms underlying craniosynostosis, a common craniofacial birth defect. The research team at Boston University Medical Campus will use a zebrafish model to study the role of the ERF transcription factor in normal skull development and how its reduction...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $250,931 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Children's Mercy Hospital in Kansas City, Missouri. The grant will fund the development and validation of a novel diagnostic modality that integrates dynamic computed tomography (4D-CT) with computational fluid dynamics (CFD) analysis to quantify upper airway obstruction in patients with Robin sequence, a congenital craniofacial condition. The research aims to create patient-specific, data-driven metrics to stratify the severity of upper airway obstruction and inform treatment decisions. The project will involve collaboration with researchers at the University of Washington and Seattle Children's Hospital, who will contribute expertise in flow modeling and clinical data analysis, respectively. This integrated 4D-CT/CFD-based diagnostic approach could be applicable to other conditions affected by upper airway obstruction, such as obstructive sleep apnea and laryngomalacia, if successfully validated in the initial target population.

Generated 7/1/25, 3:12 AM